AVTX analyst estimates
Avalo Therapeutics (AVTX) analyst ratings, the average price target and its range, and every firm's latest call.
- 7 firms rate AVTX: 5 buy, 2 hold, 0 sell.
- The average price target is $35.13 from None analysts, from $10.00 to $60.00.
Updated 2026-11-09 19:47 UTC